Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients

Nicholls et al. (Tue,) studied this question.

www.synapsesocial.com/papers/69d71f48306ad4c62a5639c4 — DOI: https://doi.org/10.1001/jama.2016.16951

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Impact of PCSK9 inhibition on coronary atheroma progression: Rationale and design of Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound (GLAGOV)· 2016 · 58 citations
2. EFFECT OF VERY HIGH-INTENSITY STATIN THERAPY ON REGRESSION OF CORONARY ATHEROSCLEROSIS: THE ASTEROID TRIAL· 2006 · 148 citations
3. Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia· 1995 · 7,481 citations
4. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): Liver regeneration and neuronal differentiation· 2003 · 1,188 citations
5. A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia· 2014 · 710 citations